Company profile
Nuo Therapeutics, Inc. CIK 1091596
Ticker
AURX (OTC)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Houston, TX 77054
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$2.51M
Total assets
$1.85M
Total liabilities
$2.80M
Stockholders' equity
-$956.6K
Cash & equivalents
$548.9K
Operating income
-$2.52M
Operating cash flow
-$865.0K
Capital expenditures
$274.8K
Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$1.14M
Free cash flow margin
—
Liabilities / assets
151.8%
Equity / assets
-51.8%
CapEx / revenue
—
Operating cash flow / net income
0.34×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$2.51M
$1.85M
$2.80M
-$956.6K
2024
—
-$2.32M
$1.19M
$675.8K
$513.7K
2023
—
-$3.17M
$1.88M
$838.7K
$1.04M
2022
—
-$3.17M
$3.05M
$856.0K
$2.19M
2021
—
-$90.7K
$1.47M
$673.1K
$792.8K
Company Details
SIC code
3841
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4/A
2026-08-31
Financials filed via
Form 10-K
filed 2026-03-30
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Houston, TX 77054
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.